Inactive Instrument

News Arsanis Inc Nasdaq

Equities

US0428731097

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	May. 01	AQ
HC Wainwright Adjusts Price Target on X4 Pharmaceuticals to $5 From $3, Maintains Buy Rating	Apr. 30	MT
X4 Pharmaceuticals to Report First-Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 7, 2024	Apr. 30	AQ
Pantherx® Rare Partner with X4 Pharmaceuticals Inc. for the Distribution of Xolremdi? (Mavorixafor), the First FDApproved Therapy Indicated for Use in Patients with Whim Syndrome	Apr. 29	CI
X4 Pharmaceuticals' Xolremdi Approved by FDA For WHIM Syndrome	Apr. 29	MT
Transcript : X4 Pharmaceuticals, Inc. - Special Call	Apr. 29
X4 Pharmaceuticals Gets FDA Approval for Xolremdi Capsules	Apr. 29	DJ
X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor) Capsules, First Drug Indicated in Patients with WHIM Syndrome	Apr. 29	AQ
X4 Pharmaceuticals, Inc. Announces FDA Approval of XOLREMDI (mavorixafor) Capsules, First Drug Indicated in Patients with Whim Syndrome	Apr. 29	CI
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)	Apr. 03	AQ
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Apr. 02	AQ
X4 Pharmaceuticals : Regulation FD Disclosure - Form 8-K	Apr. 01	PU
X4 Pharmaceuticals to Participate in Upcoming April Investor Conferences	Apr. 01	AQ
Transcript : X4 Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 21, 2024	Mar. 21
X4 Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 21	CI
X4 Pharmaceuticals: Q4 Earnings Snapshot	Mar. 21	AQ
North American Morning Briefing : Investors -2-	Mar. 21	DJ
X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Corporate Update	Mar. 21	AQ
X4 Pharmaceuticals to Report Fourth-Quarter and Full Year 2023 Financial Results and Host a Conference Call and Webcast on March 21, 2024	Mar. 12	AQ
Thinking about buying stock in Marpai, Axcelis Technologies, Amylyx Pharmaceuticals, Biomx, or X4 Pharmaceuticals?	Mar. 11	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Arsanis Inc Nasdaq

Equities

US0428731097

Summary

Filters